Abstract:Photodynamic therapy (PDT) of cancer is a clinically approved, minimally invasive therapeutic approach, combining PDT drug (photosensitizer, PS), molecular oxygen and light to produce cytotoxicity via reactive oxygen species (ROS), which are generated by the light excited PS. Most of the PS molecules fluoresce under excitation with light and fluorescence imaging (FLI) can be employed to evaluate their biodistribution and assess the intratumoral delivery before the therapeutic light application. Light absorption can also be utilized to track a PS by photoacoustic imaging (PAI). However, an excitation of the PS during assessment of its biodistribution through FLI or PAI results in premature photobleaching and causes toxicity. An involvement of a separate fluorescent (luminescent) or photoacoustic imaging probe, which provides imaging contrast in combination with PS without excitation of the latter, can allow for "see-and-treat" approach with FLI/PAI guided PDT. On the other hand, it is well-known that near-infrared (NIR) light is able to penetrate relatively deeper in comparison with visible light, due to reduced absorption and scattering. In addition to the conventional NIR window (NIR-I, ~700-950 nm), other transparency windows for biological tissues have recently been identified at ~1000-1700 nm (NIR-II), benefiting optical bioimaging due to the reduced tissue scattering and autofluorescence. Multiple NIR-II imaging probes are currently introduced both for luminescence and photoacoustic bioimaging, providing the significantly improved signal to noise ratio (SNR), imaging depth and resolution. Their combinations with PS are also being increasingly reported, though no review on this hot topic currently exists. Herein, a state-of-the-art in NIR photoluminescence (including fluorescence) and photoacoustic imaging guided PDT is presented. NIR-I and NIR-II spectral ranges are considered, along with both molecular and nanoparticle formulations for imaging guided PDT. It is expected that this review will provide a solid foundation for future translational studies in the domain of NIR imaging guided photodynamic therapy and drug delivery.

Fluorescence imaging‐guided lipid droplets‐localized photodynamic therapy

X-ray excited luminescent nanoparticles for deep photodynamic therapy

Advances in Liposome-Encapsulated Phthalocyanines for Photodynamic Therapy

Lipid Droplet‐Targetable Fluorescence Guided Photodynamic Therapy of Cancer Cells with an Activatable AIE‐Active Fluorescent Probe for Hydrogen Peroxide

Trifluoromethyl-pyrrolidone phthalocyanine nanoparticles for targeted lipid droplet imaging and in vitro photodynamic therapy in breast cancer cells

A Review of Light Sources and Enhanced Targeting for Photodynamic Therapy

Molecular And Nanoparticulate Agents For Photodynamic Therapy Guided By Near Infrared Imaging

Recent Progress in Thermally Activated Delayed Fluorescence Photosensitizers for Photodynamic Therapy

The Current Status of Photodynamic Therapy in Cancer Treatment

Recent advances in photosensitizer materials for light‐mediated tumor therapy

Anti-cancer liposomal chemophototherapy using bilayer-localized photosensitizer and cabazitaxel

A Dual‐Responsive Morphologically‐Adaptable Nanoplatform for Targeted Delivery of Activatable Photosensitizers in Precision Photodynamic Therapy

Targeted and Imaging-Guided in Vivo Photodynamic Therapy for Tumors Using Dual-Function, Aggregation-Induced Emission Nanoparticles

Internal Light Sources‐Mediated PDT Nanoplatforms: Hope for the Resolution of Traditional Penetration Problem

Photodynamic Therapy Review: Principles, Photosensitizers, Applications, and Future Directions

Photodynamic Therapy Based on Organic Small Molecular Fluorescent Dyes

Recent Advances in Photodynamic Therapy for Deep-Seated Tumors with the Aid of Nanomedicine

X-ray Activated Nanoplatforms for Deep Tissue Photodynamic Therapy

Ultrasmall Porphyrin-Silica Core-Shell Dots for Enhanced Fluorescence Imaging-Guided Cancer Photodynamic Therapy

Photodynamic Therapy: Current Status and Future Directions

Organelle-Targeted Photosensitizers for Precision Photodynamic Therapy